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Abstract
Background: We report on the validity of the computerized diagnoses of autism in a large case-
control study investigating the possible association between autism and the measles, mumps and
rubella vaccine in the UK using the General Practitioner Research Database (GPRD). We examined
anonymized copies of all relevant available clinical reports, including general practitioners' (GP)
notes, consultant, speech therapy and educational psychologists reports, on 318 subjects born
between 1973 and 1997 with a diagnosis of autism or a related disorder recorded in their
electronic general practice record.
Methods:  Data were abstracted to a case validation form allowing for the identification of
developmental symptoms relevant to the diagnosis of pervasive developmental disorders (PDDs).
Information on other background clinical and familial features was also abstracted. A subset of 50
notes was coded independently by 2 raters to derive reliability estimates for key clinical
characteristics.
Results: For 294 subjects (92.5%) the diagnosis of PDD was confirmed after review of the records.
Of these, 180 subjects (61.2%) fulfilled criteria for autistic disorder. The mean age at first recording
of a PDD diagnosis in the GPRD database was 6.3 years (SD = 4.6). Consistent with previous
estimates, the proportion of subjects experiencing regression in the course of their development
was 19%. Inter-rater reliability for the presence of a PDD diagnosis was good (kappa = .73), and
agreement on clinical features such as regression, age of parental recognition of first symptoms,
language delay and presence of epilepsy was also good (kappas ranging from .56 to 1.0).
Conclusions: This study provides evidence that the positive predictive value of a diagnosis of
autism recorded in the GPRD is high.
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Background
Of 32 epidemiological surveys of autism and pervasive
development disorders (PDDs) included in a recent
review [1], 13 were published within the last 5 years.
Increased research activity in this field of neuropsychiatry
has led to a refinement of the definition of autism that
involves a combination of qualitative impairments in lan-
guage/communication, in social interaction and in pat-
terns of play behaviours and interests. Improved
operationalisation of diagnostic definitions within nosog-
raphies has occurred (American Psychiatric Association,
1994; World Health Organization, 1992), in parallel with
the development of more precise diagnostic instruments
such as the Autism Diagnostic Interview [2] and the
Autism Diagnostic Observational Schedule [3]. There has
also been an increasing concern by the public about this
group of disorders, prompted, in part, by concern that the
rates of PDD may have increased in recent decades [4-6];
and that the cause of the increase may be due to the side
effects of vaccination [7-9] or increased exposure of young
infants to neurotoxins such as methylmercury or thimero-
sal [10].
The investigation of risk factors for autism in epidemio-
logical surveys has been limited by the small size of many
studies. The median number of cases identified in the 32
surveys reviewed was 50 children [1]. Some investigators
examined the effects of specific environmental exposures
using large samples of subjects obtained from educational
or hospital services [11-13]. These included computerized
databases obtained through research networks of general
practitioners, such as the General Practitioner Research
Database (GPRD) [14], the Doctor Independent Network
Database in the UK [15], national registers [16] and mem-
berships of consumer associations [17]. There are prob-
lems with the use of these databases because of
uncertainties about the validity of the diagnosis of the
cases. Often there is no information on specific clinical
characteristics which might allow identification of sub-
groups of individuals within the same diagnostic category
(e.g. children with autism who have regressed in the
course of their development), precluding investigation of
hypotheses proposing an association between subtypes of
PDDs and specific exposures [18].
To test the hypotheses of a link between autism and expo-
sure to combined measles, mumps and rubella vaccines,
or to other infectious agents, we designed a study based
on cases identified in the GPRD database in the UK
[19,20]. The research protocol included evaluating the
quality of diagnoses in the GPRD database by obtaining
clinical reports on a sub-sample of children included in
the study. We report the results of this validation study on
a subset of 318 cases of autism, based on the reports in the
medical files of the general practitioners through whom
these cases were identified.
Methods
The General Practice Research Database
The GPRD (previously called the VAMP (Value Added
Medical Products) Research Bank) was set up in 1987 and
is now held on behalf of the Department of Health by the
Medicines Control Agency [21]. It consists of the compu-
terised general practice medical records for around 3 mil-
lion people in the United Kingdom. The electronic record
includes demographic information such as age and sex,
details of every consultation with a general practitioner,
all prescribed drugs and vaccinations given, and details of
referrals to hospital or specialist services. It is possible to
obtain from general practitioners copies of hospital letters
regarding specific patients (in anonymised form),
although not all participating general practices provide
this service.
Practices in the GPRD originally used a modification of
the Oxford Medical Information Systems coding system to
record diagnoses [22]. Through the 1990s an increasing
number of practices changed to the READ coding system,
which is now used throughout the United Kingdom
National Health Service [23].
Selection of cases and data obtained
Of patients with a recorded diagnosis of PDD in the
GPRD, including prevalent cases when first registered, 446
were registered with 203 general practices willing to pro-
vide copies of patient records. For 80 of these patients,
records were not available as the patient was no longer
registered with the general practitioner. We obtained com-
plete case records including copies of hospital clinic letters
and specialist reports for 318 (87%) of the remaining 366
patients.
Abstraction of clinical data
The case validation form included a section on socio-
demographic data, an assessment of current level of lan-
guage and of educational status, together with estimates
of associated levels of learning disabilities. The assessment
of learning disabilities was based on available psychomet-
ric data and, when not available, on a best estimate of
intellectual functioning, classified into broad bands after
review of all the available information. A section on
health covered the lifetime occurrence of epilepsy, of
treatments with psychoactive drugs, of associated medical
disorders, the body measurements of head circumference,
weight and height, of dysmorphic syndromes and the
report of any significant non-autistic symptom in the
course of the development of the child (such as: gastroin-
testinal symptoms, infections, sleeping difficulties or
immune medical conditions). Symptoms were rated asBMC Public Health 2004, 4 http://www.biomedcentral.com/1471-2458/4/5
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being either reported or not reported since information
allowing a more detailed coding (based on severity of the
symptom, age of onset and of offset) was not available for
most cases where symptoms were reported. A section on
pregnancy and birth covered the incidence of maternal ill-
ness and infection during pregnancy, the mode of deliv-
ery, length of labour, birth weight and birth order. A
section on the early development of the child covered
major milestones (coded as normal versus delayed), the
age of first words and phrases (coded either as an age in
months or as an approximate age band), language delay
(defined as single words not occurring until after 24
months of age or phrase speech not occurring until after
36 months of age), any regression or loss of skill at any
point in the course of development and, when present,
the type of skill lost. For those cases with some regression/
loss of skills, a global judgment was provided by the rater
on whether the developmental pattern was suggestive of a
definite regression/loss of acquired skills as opposed to
fluctuating development with an uneven rate of skill
acquisition. As age on onset of first symptoms is a key
diagnostic criterion, this was operationalised in three dif-
ferent ways. First, we recorded the age at which the parents
first recognized signs of developmental delay or variation
in their child and the type of symptoms that first triggered
their concerns. Second, we recorded age at the date of the
first letter on file with concerns about a developmental
problem in the child (e.g. a referral letter from the GP to a
specialist to gain an opinion). Third, rater's assessment of
age of onset was based on the rater's judgment of age of
first symptom onset, irrespective of actual parental and or
professional recognition of these symptoms at the time.
Specific or global developmental disorders were identified
in the first and second-degree relatives, along with specific
medical (especially autoimmune) and psychiatric
disorders.
The overall diagnostic rating of a child was made with two
approaches, one algorithmic and one based on judgment
of the rater. First, reports were searched for evidence of 12
specific DSM-IV symptoms for PDDs. A computer diag-
nostic algorithm using DSM-IV symptoms ratings was
devised. Instead of using the typical DSM-IV algorithm (2
social symptoms, 1 communication/language symptoms,
1 repetitive behaviour symptom, together with at least 6
symptoms out of the 12 possible), we generated an algo-
rithm to take account of the uneven quality of the data
across the subjects. The algorithm generated a PDD diag-
nosis when at least three out of the 12 DSM-IV symptoms
were scored, with the further constraint that there would
be at least 1 symptom in the social domain and 1 symp-
tom in either the communication/language or the repeti-
tive behaviour domain. This algorithm is consistent with
that used in a recent survey using a comparable record
review approach [5]. Second, when all the documentation
had been reviewed, the rater was asked to make a global
judgement regarding the presence or absence of a PDD in
the child and, when present, to provide a diagnosis for the
specific subtype of PDD whenever possible. A global
index of confidence in the rater's judgment about the
PDD diagnosis was also derived.
Raters and inter-rater reliability
The two raters were a child psychiatrist (EF) and a psy-
chologist (LH) both with long experience in the field of
autism. LH reviewed and coded all the files. In order to
obtain reliability estimates on the rating procedure, a sub-
set of 50 medical notes chosen at random amongst the
318 records was rated blindly by EF. Records that posed
particular coding difficulties were identified and consen-
sus ratings were derived by the two raters at the end of the
study. These records were eligible to be selected for the
inter-rater reliability study. All ratings were made blind to
the child's history of immunization.
Statistical analysis
All data were analyzed with SPSS and SAS with conven-
tional chi-square and Fisher exact tests for categorical var-
iables and Student's t test for continuous variables. Inter-
rater reliability was measured with the kappa coefficient
for categorical ratings and with the intraclass correlation
coefficient (ICC) for continuous measures [24]. Through-
out, a p value of .05 was chosen as the level of statistical
significance. Missing data occurred at high rates for many
variables included in the case validation forms and, as a
result, we report both absolute and relative frequencies.
Results
Sample characteristics
Medical notes for 318 subjects were obtained. They varied
in quality and exhaustiveness. For some children, GP
records included several consultant reports, speech and
language assessments, and educational psychology
reports. For other children, the information available was
scanty, with sometimes the only available data consisting
of one, or a few, letters between the GPs and consultants.
A high proportion of records had missing data on parental
age, socio-economic status, and detailed psychometric
assessment of the child and therefore the frequencies of
these variables are not described here. Of the 318 children
whose medical forms were obtained, the raters confirmed
a diagnosis of PDD in 294 children (92.5%). Compared
to children with a confirmed PDD diagnosis, children for
whom the diagnosis was not confirmed (n = 24) had sig-
nificantly fewer PDD symptoms (2.1 vs 6.2; p < .001),
higher language level (phrase speech: 80% vs 45%;
p=.051), and more frequent parental concern arising for
the first time after the age of 3 years (20% vs 2.9%;
p=.024). No significant differences were found with
respect to gender, birth year, presence of epilepsy orBMC Public Health 2004, 4 http://www.biomedcentral.com/1471-2458/4/5
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regression or in the average age at first diagnosis in the
GPRD database.
The main characteristics of the 294 children with a con-
firmed diagnosis of PDD are shown in Table 1. The male/
female ratio was 4.25:1. A third of the children had no
phrase speech when language level was recorded (at a
mean age of 7.9 years). About a third of children had esti-
mated intellectual skills falling into the normal range. 55
(19%) children showed clear evidence of regression and
loss of acquired skills, and a further 34 had a developmen-
tal pattern consistent with an uneven and slow rate of
acquisition of new skills as they grew up. The rate of
regression and of epilepsy (18%) are consistent with those
described in other surveys of autistic children. The mean
number and pattern of DSM-IV symptoms was consistent
with the diagnostic concepts of autism, especially as
symptoms of social deficits appeared to be reported more
frequently (Table 1). The computer-based algorithm iden-
tified 237 (80.6%) of the 294 cases as having a PDD.
It was possible to allocate a more specific diagnosis to 217
of the 294 children with PDD. This was autistic disorder
in 180 children (82.9%), Asperger Disorder (AD) in 18
children (8.3%), and PDDNOS (Pervasive Developmen-
tal Disorder Not Otherwise Specified) in 19 children
(8.8%). The confidence level in the diagnostic subtype
was generally high (high in 67.1%; medium in 19.7%,
and low in 13.1%). In the remaining 77 children (26.2%),
the quality of the data did not allow for the diagnosis of a
specific PDD subtype. A comparison of the PDD children
with and without a more specific diagnosis showed that
children without a PDD subtype were comparable to chil-
dren with autism with respect to language level and intel-
Table 1: Characteristics of 294 Children with PDD
N%
Male 238 81.0
Diagnosis subtype Autism 180 61.2
PDD NOS 19 6.5
Asperger 18 6.1
Unknown 77 26.2
Birth year 1973 – 1977 19 6.5
1978 – 1982 31 10.7
1983 – 1987 65 22.3
1988 – 1992 115 39.5
1993 – 1997 61 21.0
Past or current epilepsy 53 18.0
Overall level of language1 Mute 45 16.9
Single words 52 19.5
Few phrases 50 18.7
Phrase speech 120 44.9
Estimated intellectual functioning Normal IQ 89 34.5
Mild MR 99 38.4
Moderate MR 49 19.0
Severe MR 21 8.1
Age of parental recognition (months) 0 – 12 82 39.6
13 – 24 94 45.4
25 – 36 25 12.1
36+ 6 2.9
Regression 55 19.0
NM e a n S D
Age at first GPRD diagnosis (years) 278 6.25 4.52
Age at first letter (years) 282 4.50 3.84
Age at last report on note (years) 289 10.66 5.65
Mean number of DSM-IV PDD symptoms
–Total 294 6.23 4.17
–Language/communication 294 1.66 1.43
–Social interaction 294 2.53 1.82
–Repetitive behaviours 294 2.05 1.76
1: Mean age when language level was recorded was: 7.86 years (SD: 4.50).BMC Public Health 2004, 4 http://www.biomedcentral.com/1471-2458/4/5
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lectual functioning but closer to the children with either
PDDNOS or AD with respect to age at first electronic diag-
nosis and rate of regression. Compared to both other
groups, they had significantly fewer PDD symptoms, most
certainly reflecting the poorest quality of the notes that
precisely precluded a final sub-typing to be attained by
raters.
The mean age at first parental concern regarding their
child's development was 16.8 months (SD = 9.8) in 142
children where a precise age could be estimated. Age of
first recognition of symptoms in medical records could be
estimated in broad age bands in 207 subjects and
occurred before age 3 years in 201 subjects (97.1%).
Onset of first symptoms was also determined by the rater's
judgment, based on the medical records, in 91 subjects
and was 12 months (SD = 8.5). In 88 subjects where both
a parental and a rater age of onset were available, the rater
mean age of onset was significantly younger than the age
at parental concern (12.1 months vs 13.3 months; paired
t-test; p = 0.02). Finally, the presence of a PDD in a first-
degree relative of the index child was reported in 7.8% of
the sample, consistent with other surveys of PDDs [4].
We compared children with an autistic disorder diagnosis
with children with another PDD diagnosis (Table 2). The
PDDNOS/AD group had significantly fewer language and
intellectual impairments and were on average 2.3 years
older than their autistic counterparts when recorded in the
Table 2: Comparison of Children with Autism or other PDD (N = 217)
Autism PDDNOS & Asperger P
(N = 180) (N = 37)
N%N%
Male Sex 146 81.1 31 83.8 .703
Birth year 1973 – 1977 11 6.2 - - .217
1978 – 1982 15 8.4 3 8.3
1983 – 1987 43 24.2 11 30.6
1988 – 1992 68 38.2 18 50.0
1993 – 1997 41 23.0 4 11.1
Past or current epilepsy 29 16.1 5 13.5 .692
Overall level of language1 Mute 31 17.7 - - .000
Single words 38 21.7 1 2.9
Few phrases 39 22.3 5 14.7
Phrase speech 67 38.3 28 82.4
Estimated intellectual Functioning Normal IQ 42 25.3 27 81.8 .000
Mild MR 78 47.0 4 12.1
Moderate MR 34 20.5 2 6.1
Severe MR 12 7.2 - -
Age of parental recognition (months) 0 – 12 60 41.1 8 32.0 .176
13 – 24 68 46.6 11 44.0
25 – 36 16 11.0 4 16.0
36+ 2 1.4 2 8.0
Regression2 43 24.0 3 8.3 .036
Language delay Yes probable/definite 162 96.4 13 44.8 .000
Autism PDD NOS & Asperger P
N = 180 N = 37
NM e a n S DN M e a n S D
Age at first GPRD diagnosis (years) 167 5.45 4.06 36 7.77 3.68 .002
Age at first letter (years) 174 3.45 2.48 36 5.08 3.39 .009
Age at last report on note (years) 176 10.50 5.61 36 10.51 4.28 .992
Mean number of DSM-IV PDD symptoms
–Total 180 7.67 3.92 37 7.24 3.81 .543
–Language/communication 180 2.14 1.41 37 1.62 1.28 .040
–Social interaction 180 3.04 1.76 37 3.24 1.57 .525
–Repetitive behaviours 180 2.49 1.73 37 2.38 2.06 .732
1: Mean age when language was recorded was: 7.77 years (SD: 4.31). 2: 9 (12%) out of 77 children in unknown diagnostic group had regressionBMC Public Health 2004, 4 http://www.biomedcentral.com/1471-2458/4/5
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GPRD database. Regression was less often reported in the
PDDNOS/AD group.
Since regression and loss of skills is a clinical feature of
potential interest for our main study, we examined further
the clinical correlates of regression. As regression was
infrequent in the PDDNOS/AD group and as these chil-
dren were different from children with autism with
respect to age at diagnosis and severity, we restricted this
analysis to those children with a diagnosis of autistic dis-
order (Table 3). The regressive and non regressive groups
differed with respect to language level and intellectual
functioning where children with regression exhibited
lower levels of functioning at the final assessment. They
also had a significantly lower age at the first referral letter
on file mentioning a developmental problem.
Trends over time in clinical features that are known to
indicate autism severity were also examined for the autism
group (Table 4). Birth years were grouped into 5-year
intervals. There was a significant trend for decreasing lev-
els of mental retardation and for an increasing proportion
of males, suggesting that clinical presentation became less
severe over time. Age differences in the birth cohorts made
the interpretation of trend for phrase speech and for epi-
lepsy more difficult to interpret. Other clinical features,
including regression, did not change significantly with
time.
Table 3: Autistic Children with or without Regression (N = 1791)
Regression
No (N = 136) Yes (N = 43) P
N%N%
Male Sex 114 83.8 32 74.4 .166
Birth year 1973 – 1977 8 5.9 3 7.0 .789(trend)
1978 – 1982 12 8.9 3 7.0
1983 – 1987 31 23.0 12 27.9
1988 – 1992 56 41.5 12 27.9
1993 – 1997 28 20.7 13 30.2
Past or current epilepsy 21 15.4 7 16.3 .895
Overall level of language2 Mute 21 15.9 10 23.3 .065 (trend)
Single words 27 20.5 11 25.6
Few phrases 28 21.2 11 25.6
Phrase speech 56 42.4 11 25.6
Estimated intellectual functioning Normal IQ 35 27.8 7 17.5 .054 (trend)
Mild MR 61 48.4 17 42.5
Moderate MR 22 17.5 12 30.0
Severe MR 8 6.3 4 10.0
Age of parental recognition (months) 0 – 12 45 43.3 15 35.7 .897 (trend)
13 – 24 45 43.3 23 54.8
25 – 36 12 11.5 4 9.5
36+ 2 1.9 - -
Language delay Yes probable/definite 122 97.6 40 93.0 .163
Regression
No (N = 136) Yes (N = 43) P
NM e a n S D NM e a n S D
Age at first GPRD diagnosis (years) 127 5.39 4.01 40 5.63 4.29 .746
Age at first letter (years) 133 3.66 2.75 41 2.76 1.02 .002
Age at last report on note (years) 134 10.61 5.65 42 10.15 5.56 .646
Mean number of DSM-IV PDD symptoms
–Total 136 7.51 3.94 43 8.35 3.67 .221
–Language/communication 136 2.08 1.43 43 2.37 1.29 .236
–Social interaction 136 3.04 1.66 43 3.14 2.02 .738
–Repetitive behaviours 136 2.40 1.73 43 2.84 1.68 .144
1: Autism children only. One child had no information about regression. 2: Mean age when language was recorded was: 7.65 years (SD: 4.39).BMC Public Health 2004, 4 http://www.biomedcentral.com/1471-2458/4/5
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Interrater reliability
Interrater reliability was examined on the subset of 50 ran-
domly selected children. Agreement between the two
raters was good for the presence/absence of a PDD in the
child (Kappa = .73), and there were only 2 cases where
raters originally disagreed. The agreement on the number
of DSM-IV symptoms was excellent (ICC = .92). PDD
symptom scores for each of the three domains separately
showed high intra-class correlations as well, with ICC val-
ues of .87 for the social domain, .75 for the communica-
tion/language domain, and of .91 for repetitive
behaviours. The agreement was also good to excellent on
the presence/absence of language delay (Kappa = 1.0), of
regression or loss of skills in the course of development
(Kappa = .58), of epilepsy (Kappa = .84), on overall lan-
guage level (Kappa = .62), on estimate of intellectual
functioning coded on 3 levels (normal range, mild retar-
dation, moderate to profound retardation) (Kappa = .72),
and on the presence/absence of any developmental disor-
der amongst first degree relatives (Kappa = .74). Reliabil-
ity was lower for regression due to the difficulty in
differentiating loss of skills from developmental stagna-
tion and to establish language level before the reported
loss occurred.
Discussion
We have shown that the positive predictive value of a
diagnosis of autism recorded in the electronic health
record of patients in the General Practice Research Data-
base is high, and higher than in a previous study where the
diagnosis of autism was confirmed in 80% of 83 subjects
with a GPRD computer record of autism [25]. A high pos-
itive predictive value for other morbidity data recorded in
the GPRD has been found for a range of other conditions.
For example 94% of cases of cataract identified had their
diagnosis confirmed by a review of hospital eye service
discharge summaries [26] and a recorded diagnosis of
myocardial infarction was confirmed in over 90% of cases
[27]. In our study, the diagnosis of PDD was confirmed by
expert review of the notes in 92.5% of the cases. Amongst
the unconfirmed cases were several records with poor
quality data which precluded a positive confirmation of
the diagnosis. A North London study based on a disability
register identified a similar proportion of confirmed cases
(89%) in their diagnostic validation [28]. The study
design precluded an estimate of the sensitivity of a GP's
diagnosis of a PDD, that is the percentage of children with
a PDD who did not have this recorded in the GP records.
This would have required a much more extensive study.
The characteristics of the children with PDD were consist-
ent with those of published studies on autistic samples.
Thus, for children with an autistic disorder from this
study, the male/female ratio was 4.3:1 (146/34) and the
proportion of subjects without intellectual impairments
was 25.3%; these results compare well to respective fig-
ures of 4.3:1 and 30% deriving from recent reviews of epi-
demiological surveys of autism [1]. Equally, the 7.8% risk
of PDD in the first-degree relatives is in line with current
estimates [29]. Similarly, the rate of 19% (24% in the
autism group) for regression in the course of the develop-
ment are consistent with the rates reported in earlier ([30]:
Table 4: Characteristics of 1781 Children with Autism over five year intervals
Age interval
73 – 77 78 – 82 83 – 87 88 – 92 93 – 97 P (for trend)
N%N%N%N%N%
Male Sex 8 72.7 12 80.0 32 74.4 55 80.9 38 92.7 .058
Past or current epilepsy2 4 36.4 4 26.7 5 11.6 11 16.2 4 9.8 .046
Phrase speech 3 27.3 10 66.7 19 47.5 24 35.8 10 24.4 .044
Normal/mild moderate 
Functioning
4 36.4 9 60.0 30 75.0 45 71.4 31 86.1 .003
Age of parental recognition 
<24 months
8 80.0 9 81.8 30 85.7 47 88.7 34 91.9 .198
Regression 3 27.3 3 20.0 12 27.9 12 17.6 13 31.7 .789
Probable/definite Language 
delay3
9 81.8 11 91.7 41 100.0 62 96.9 38 97.4 .069
DSM-IV Symptoms:
–Mean 6.91 6.00 8.16 7.62 8.29 .127
–SD 4.13 3.70 4.48 3.19 4.24
1: Two children had no information about date of birth. 2: Combines definite and possible cases. 3: Mean age when language was recorded was: 7.65 
years (SD: 4.39).BMC Public Health 2004, 4 http://www.biomedcentral.com/1471-2458/4/5
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31.3%) or more recent ([31]: 25%; [4]: 15.6%) epidemi-
ological surveys or in various clinical samples ([32]:
37.2%; [33]: 29.6%; [34]: 30%). The relatively wide range
of regression rates across studies reflects the different def-
initions and methods of data collection used in these
studies. Therefore, on a range of indices, our sample char-
acteristics were typical of studies including well character-
ized PDD children.
Within the PDD spectrum, a relatively small proportion
was identified as having a PDDNOS or Asperger Disorder.
This would not have been surprising in earlier years, since
the diagnosis of Asperger Disorder was not defined until
1992, and therefore many of these children will not have
received a diagnosis that lead to ascertainment in the
sample. However, although their number increased, there
were still few children with these diagnoses among the
most recent birth cohorts in the GPRD. This was unex-
pected: evidence from epidemiological surveys suggests
that the prevalence of PDDNOS is higher than that of
autistic disorder [1,4]. This is consistent with three alter-
native explanations: first, a precise differentiation
between autism and PDDNOS has not been possible in
our study (maybe due to our particular mode of data col-
lection), leading to an inclusion of children with atypical
forms of autism in the autistic disorder group; second,
that some children with atypical autism were not diag-
nosed as having a PDD at all; and third, that among those
with a PDD diagnosis, the recording of diagnosed
PDDNOS into GPRD is less complete than of autism. The
fact that the severity of autism, as indicated by gender
ratio, intellectual and language levels, decreased over time
supports the first interpretation. It could be the case, how-
ever, that this trend also reflects a genuine change in the
association between autistic disorder and mental retarda-
tion, possibly due to earlier diagnosis and intervention.
Conclusions
We conclude from this validation study that the positive
predictive value of the diagnoses of autistic spectrum dis-
orders or of the broad category of PDDs is good in the
GPRD. The differentiation of PDD subtypes within this
broad PDD class was, however, less good.
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